RENE GONZALEZ to Molecular Targeted Therapy
This is a "connection" page, showing publications RENE GONZALEZ has written about Molecular Targeted Therapy.
Connection Strength
0.498
-
Novel therapies in melanoma. Immunotherapy. 2011 Dec; 3(12):1461-9.
Score: 0.313
-
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling. Int J Cancer. 2024 Nov 15; 155(10):1792-1807.
Score: 0.047
-
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers. Cancer. 2024 May 15; 130(10):1784-1796.
Score: 0.045
-
NCCN Guidelines Insights: Melanoma, Version 3.2016. J Natl Compr Canc Netw. 2016 08; 14(8):945-58.
Score: 0.027
-
A review of novel therapies for melanoma. Am J Clin Dermatol. 2014 Aug; 15(4):323-37.
Score: 0.024
-
New targeted therapies in melanoma. Cancer Control. 2013 Oct; 20(4):282-8.
Score: 0.022
-
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. Lancet Oncol. 2012 Aug; 13(8):782-9.
Score: 0.020